Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease

NCT00359944 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
171
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sumitomo Pharma America, Inc.